(Q43848137)

27 November 2017

Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections (English)

1 reference

27 November 2017

0 references

S Chakrabarti

1

1 reference

27 November 2017

K E Collingham

2

1 reference

27 November 2017

H Osman

3

1 reference

27 November 2017

C D Fegan

4

1 reference

27 November 2017

D W Milligan

5

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Bone Marrow Transplantation

27 November 2017

1 reference

27 November 2017

28

1 reference

27 November 2017

9

1 reference

27 November 2017

879-881

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703251

27 November 2017

0 references

cites work

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703251

Rapid detection by reverse hybridization of mutations in the UL97 gene of human cytomegalovirus conferring resistance to ganciclovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703251

Differences between the quantitative antigenemia assay and the cobas amplicor monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703251

Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703251

Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703251

Failure of cidofovir to reduce CMV-antigenemia in a child transplanted from a matched unrelated donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703251

Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703251

A survey of allogeneic bone marrow transplant programs in the United States regarding cytomegalovirus prophylaxis and pre-emptive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703251

inferred from DOI database lookup

7 January 2021

based on heuristic

Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703251

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.BMT.1703251

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference